Related Experiment Video

Updated: Jun 16, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?

Kathleen A Hazlewood1, Sara D Brouse, William D Pitcher

  • 1Texas Tech University Health Sciences Center, Dallas, TX, USA.

The American Journal of Medicine
|January 28, 2010
PubMed

Insights

Vancomycin dosing strategies impact patient outcomes. Aggressive dosing may increase nephrotoxicity risk, especially in patients with risk factors, while inadequate dosing can lead to treatment failures and resistance.

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Background:

  • Vancomycin-associated nephrotoxicity rates were historically low (0-5%) but have become a concern with evolving treatment practices.
  • Treatment failures with standard vancomycin doses for methicillin-resistant Staphylococcus aureus (MRSA) infections have prompted higher, supra-therapeutic dosing.
  • Clinical practice guidelines recommend higher vancomycin trough concentrations (10-20 microg/mL), potentially increasing nephrotoxicity risk.

Purpose of the Study:

  • To evaluate the association between vancomycin dosing strategies and nephrotoxicity.
  • To examine the impact of aggressive vancomycin dosing on kidney injury in patients with MRSA infections.
  • To highlight the importance of appropriate vancomycin dosing to balance efficacy and safety.

Main Methods:

  • Review of clinical trials and studies comparing vancomycin dosing regimens.
  • Analysis of factors confounding vancomycin-associated nephrotoxicity, including concomitant nephrotoxins and patient comorbidities.
  • Assessment of the relationship between vancomycin trough concentrations and adverse renal events.

Main Results:

  • Increased nephrotoxicity rates are linked to aggressive vancomycin dosing, particularly in patients with pre-existing risk factors.
  • Vancomycin's nephrotoxicity risk appears minimal in patients without specific risk factors for kidney injury.
  • Inadequate vancomycin dosing is associated with treatment failures and the emergence of heteroresistant MRSA.

Conclusions:

  • Aggressive vancomycin dosing requires careful consideration due to increased nephrotoxicity risk, especially in vulnerable patients.
  • Clinicians should adhere to established guidelines for vancomycin dosing to optimize treatment efficacy and minimize renal adverse events.
  • Alternative antibiotics should be considered for patients where guideline-adherent vancomycin dosing is not feasible or desired due to potential risks.

More Related Videos

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...